OCEANIC-AF Study Investigating Asundexian Stopped Early Due to Lack of Efficacy

Berlin, November 19, 2023– OCEANIC-AF, a phase III study investigating asundexian compared to apixaban (a direct oral anticoagulant) in patients with atrial fibrillation at risk for stroke is being stopped early. This decision is based on the...
Source: Drugs.com - Clinical Trials - Category: Pharmaceuticals Source Type: clinical trials